Uncontrolled Clinical Trial of Quality- and Quantity-cultured Peripheral Blood Mononuclear Cell Treatment for Androgenic Alopecia
We demonstrated the safety and effectiveness of MNC-QQ cell treatment for androgenic alopecia. Our results suggest MNC-QQ cells as an alternative therapy for androgenic alopecia.
Authors
- Yoshio Ikeda
- Yuki Morishige
- Rie Ito (ORCID: https://orcid.org/0000-0001-9026-4939)
- Rica Tanaka (ORCID: https://orcid.org/0000-0002-6370-0915)
- Ayana Shikanai
- Sen Jiang (ORCID: https://orcid.org/0000-0002-8605-3116)
- Satoshi Fujimura (ORCID: https://orcid.org/0009-0005-4282-8476)
- Ai Sugawara
- Satomi Furukawa
Institutions
- Kyorin University (JP)
- Juntendo University (JP)
- Kishokai Medical Corporation (JP)
Publication Details
- Journal
- Plastic & Reconstructive Surgery
- Published
- 2025-10-20
- DOI
- https://doi.org/10.1097/prs.0000000000012553
- Primary Topic
- Hair Growth and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00